Literature DB >> 16792671

Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.

M Paz Morante1, J Briones, E Canto, H Sabzevari, R Martino, J Sierra, J L Rodriguez-Sanchez, S Vidal.   

Abstract

During the effector phase of graft-versus-host disease (GvHD) response, donor T cells play an essential role and they are believed to change the expression of activation and co-stimulatory markers associated with functional alloreactivity. We analysed the expression of CD25, CD69, HLA-DR, CD154 and CD134 on CD4+ and CD8+ T cells by flow cytometry during acute GvHD (aGvHD) in 24 patients receiving human leucocyte antigen (HLA)-identical stem cell transplants. Expression of these molecules in nine patients with stages I-IV aGvHD was compared with 15 patients without aGvHD (n = 15). Serial analysis showed that peripheral blood of aGvHD patients presented a significant increase of CD4+ CD25+ cells (P < 0.03), CD4+ CD69+ (P < 0.04) and CD4+ CD134+ cells (P < 0.01). Additionally, there was a significant increase in CD8+ cells expressing CD134 (P = 0.007) and CD154 (P = 0.02). After resolution of aGvHD, the increased expression of these molecules returned to values comparable to patients without aGvHD. Only two of the 15 patients without clinical signs of aGvHD presented activated T cells that could not be attributed to development of aGvHD. In summary, our data show that multiple activation molecules are preferentially up-regulated on CD4+ and CD8+ T cells from patients with aGvHD. These patients had a significant increase in the expression of the co-stimulatory molecules CD134 and CD154.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16792671      PMCID: PMC1942002          DOI: 10.1111/j.1365-2249.2006.03104.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Correlation of peripheral blood OX40+(CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation.

Authors:  A Kotani; T Ishikawa; Y Matsumura; T Ichinohe; H Ohno; T Hori; T Uchiyama
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

2.  LIGHT, a new TNF superfamily member, is essential for memory T helper cell-mediated activation of dendritic cells.

Authors:  Yannis Morel; Alemseged Truneh; Régis T Costello; Daniel Olive
Journal:  Eur J Immunol       Date:  2003-11       Impact factor: 5.532

3.  Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.

Authors:  B R Blazar; B S Kwon; A Panoskaltsis-Mortari; K B Kwak; J J Peschon; P A Taylor
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

Review 4.  T-cell co-signalling molecules in graft-versus-host disease.

Authors:  J Tanaka; M Asaka; M Imamura
Journal:  Ann Hematol       Date:  2000-06       Impact factor: 3.673

5.  Limiting dilution analysis of interleukin-2 producing helper T-cell frequencies as a tool in allogeneic hematopoietic cell transplantation.

Authors:  Søren L Petersen; Igor A Sidorov; Charlotte A Russell; Ebbe Dickmeiss; Lars L Vindeløv
Journal:  Transplantation       Date:  2005-09-15       Impact factor: 4.939

6.  Distinctive response of naïve lymphocytes from cord blood to primary activation via TCR.

Authors:  Elisabet Cantó; Jose Luis Rodriguez-Sanchez; Silvia Vidal
Journal:  J Leukoc Biol       Date:  2003-09-12       Impact factor: 4.962

7.  Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.

Authors:  Krzysztof Kalwak; Ewa Gorczyńska; Jacek Toporski; Dominik Turkiewicz; Malgorzata Slociak; Marek Ussowicz; Elzbieta Latos-Grazyńska; Marzena Król; Janina Boguslawska-Jaworska; Alicja Chybicka
Journal:  Br J Haematol       Date:  2002-07       Impact factor: 6.998

8.  Clinical value of the flow cytometric method for measuring lymphocyte subset activation: spontaneous activation of T-cell subpopulations is associated with acute GvHD.

Authors:  K Kalwak; D Turkiewicz; M Ussowicz; E Gorczyńska; J Toporski; R Ryczan; B Rybka; D Noworolska-Sauren; A Chybicka
Journal:  Transplant Proc       Date:  2003-06       Impact factor: 1.066

9.  CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans.

Authors:  Marta Stanzani; Sergio L R Martins; Rima M Saliba; Lisa S St John; Susan Bryan; Daniel Couriel; John McMannis; Richard E Champlin; Jeffrey J Molldrem; Krishna V Komanduri
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

10.  CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis.

Authors:  P J Blair; J L Riley; D M Harlan; R Abe; D K Tadaki; S C Hoffmann; L White; T Francomano; S J Perfetto; A D Kirk; C H June
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

View more
  12 in total

1.  CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectors.

Authors:  Xupeng Ge; Julia Brown; Megan Sykes; Vassiliki A Boussiotis
Journal:  Biol Blood Marrow Transplant       Date:  2008-05       Impact factor: 5.742

Review 2.  Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).

Authors:  D H Wagner
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

3.  Programmed death-1 controls T cell survival by regulating oxidative metabolism.

Authors:  Victor Tkachev; Stefanie Goodell; Anthony W Opipari; Ling-Yang Hao; Luigi Franchi; Gary D Glick; James L M Ferrara; Craig A Byersdorfer
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

4.  Imaging activated T cells predicts response to cancer vaccines.

Authors:  Israt S Alam; Aaron T Mayer; Idit Sagiv-Barfi; Kezheng Wang; Ophir Vermesh; Debra K Czerwinski; Emily M Johnson; Michelle L James; Ronald Levy; Sanjiv S Gambhir
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

5.  Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis.

Authors:  Nam-Sihk Lee; Laura Barber; Ali Kanchwala; Carter J H Childs; Yash P Kataria; Marc A Judson; Mark A Mazer; Sergio Arce
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

6.  Visualization of Activated T Cells by OX40-ImmunoPET as a Strategy for Diagnosis of Acute Graft-versus-Host Disease.

Authors:  Israt S Alam; Federico Simonetta; Lukas Scheller; Aaron T Mayer; Robert Negrin; Sanjiv S Gambhir; Surya Murty; Ophir Vermesh; Tomomi W Nobashi; Juliane K Lohmeyer; Toshihito Hirai; Jeanette Baker; Kenneth H Lau
Journal:  Cancer Res       Date:  2020-09-08       Impact factor: 12.701

7.  T-cell costimulatory molecules in acute-graft-versus host disease: therapeutic implications.

Authors:  Javier Briones; Silvana Novelli; Jorge Sierra
Journal:  Bone Marrow Res       Date:  2010-09-21

8.  Anti-CMV-IgG positivity of donors is beneficial for alloHSCT recipients with respect to the better short-term immunological recovery and high level of CD4+CD25high lymphocytes.

Authors:  Emilia Jaskula; Dorota Dlubek; Agnieszka Tarnowska; Janusz Lange; Monika Mordak-Domagala; Krzysztof Suchnicki; Mariola Sedzimirska; Agata Borowik; Sylwia Mizia; Andrzej Lange
Journal:  Viruses       Date:  2015-03-23       Impact factor: 5.048

9.  In vivo expansion of co-transplanted T cells impacts on tumor re-initiating activity of human acute myeloid leukemia in NSG mice.

Authors:  Malte von Bonin; Martin Wermke; Kadriye Nehir Cosgun; Christian Thiede; Martin Bornhauser; Gerard Wagemaker; Claudia Waskow
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

10.  Human Herpesvirus-6B Reactivation Is a Risk Factor for Grades II to IV Acute Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Tuan L Phan; Kristen Carlin; Per Ljungman; Ioannis Politikos; Vicki Boussiotis; Michael Boeckh; Michele L Shaffer; Danielle M Zerr
Journal:  Biol Blood Marrow Transplant       Date:  2018-04-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.